Healthcare company-building profile
Coulter-Drexel Translational Research Partnership Program
Drexel University (School of Biomedical Engineering, Science and Health Systems)
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- University accelerator
- Organization
- Drexel University (School of Biomedical Engineering, Science and Health Systems)
- Organization type
- University
- Location
- Philadelphia, Pennsylvania
- Company stage served
- Research or idea stage
- Cohort or participation model
- Annual project funding cycle with oversight committee review
- Investment or funding offered
- Yes
- Published investment terms
- Non-dilutive annual translational grants funded by the Wallace H. Coulter Foundation; amounts not published
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
The Coulter-Drexel Translational Research Partnership promotes, develops and supports innovations to improve patient care through mentoring, project management and annual grants sponsored by the Wallace H. Coulter Foundation. It funds interdisciplinary teams pairing biomedical engineers with clinicians on projects aimed at commercialization and clinical adoption. Featured projects include injectable hydrogels delivering minocycline for spinal cord injury, immunomodulatory hydrogel dressings and a megabase DNA sequencing system. The program also runs a fellowship and an investment forum with an industry advisory board.
What the program publicly emphasizes
Focus areas and features
- Category: University accelerator
- Program structure: Annual project funding cycle with oversight committee review
- Published terms: Non-dilutive annual translational grants funded by the Wallace H. Coulter Foundation; amounts not published
Sources
External source links open in a new tab.